26.06.2017 • NewsCastingCMIElaine Burridge

Polytek and CMI Set to Merge

(c) XXLPhoto/Shutterstock
(c) XXLPhoto/Shutterstock

US specialty polymer firms Polytek Development Corp. and California Medical Innovations (CMI) are to merge their businesses. The combined company will be led by Polytek CEO Jonathan Kane.

Financial terms of the transaction were not disclosed.

"The merger of the two companies creates a portfolio of products for our industries, unmatched by any competitor in the world, with a coast-to-coast presence that allows us to respond more quickly than ever before," Kane said.

Based in Easton, Pennsylvania, Polytek makes specialty polymers, including polyurethane elastomers and casting resins, silicones, epoxies and latex, used primarily in mold-making and casting applications for the industrial, construction, entertainment, fine arts and technology sectors.

CMI of Pomona, California, formulates and compounds latex, plastisols and thermoplastic elastomers for a variety of industries.

The companies said the merger will enhance their performance and provide a stronger nationwide presence. In addition, the collaboration of their R&D departments and sophisticated manufacturing facilities at both locations will offer more opportunities for customized solutions.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.